Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
Jean‐Michel Molina, Constance Delaugerre, J. Le Goff, et al.
Médecine et Maladies Infectieuses (2020) Vol. 50, Iss. 4, pp. 384-384
Open Access | Times Cited: 780

Showing 1-25 of 780 citing articles:

Coronavirus Disease 2019–COVID-19
Kuldeep Dhama, Khan Sharun, Ruchi Tiwari, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 4
Open Access | Times Cited: 1786
Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1654
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby, Marion Mafham, Louise Linsell, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 21, pp. 2030-2040
Open Access | Times Cited: 1175
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2020) Vol. 78, Iss. 7, pp. e83-e102
Open Access | Times Cited: 1010
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Yung-Fang Tu, Chian‐Shiu Chien, Aliaksandr A. Yarmishyn, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2657-2657
Open Access | Times Cited: 708
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
Nicholas J. Mercuro, Christina Yen, David Shim, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 9, pp. 1036-1036
Open Access | Times Cited: 701
COVID-19: Immunology and treatment options
Susanna Felsenstein, Jenny A. Herbert, Paul McNamara, et al.
Clinical Immunology (2020) Vol. 215, pp. 108448-108448
Open Access | Times Cited: 657
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux, Thomas Henry, Alexandre Bélot, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102567-102567
Open Access | Times Cited: 651
An Update on Current Therapeutic Drugs Treating COVID-19
Renyi Wu, Lujing Wang, Hsiao‐Chen Dina Kuo, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 3, pp. 56-70
Open Access | Times Cited: 600
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement
Oren K. Fix, Bilal Hameed, Robert J. Fontana, et al.
Hepatology (2020) Vol. 72, Iss. 1, pp. 287-304
Open Access | Times Cited: 460
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
Matthieu Mahévas, Viet-Thi Tran, Mathilde Roumier, et al.
BMJ (2020), pp. m1844-m1844
Open Access | Times Cited: 438
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Joydeb Majumder, Tamara Minko
The AAPS Journal (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 430
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Remo H.M. Furtado, Otávio Berwanger, Henrique Fonseca, et al.
The Lancet (2020) Vol. 396, Iss. 10256, pp. 959-967
Open Access | Times Cited: 360
COVID-19: A Multidisciplinary Review
Nour Chams, Sana Chams, Reina Badran, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 359
Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
Joseph Magagnoli, Siddharth Narendran, Felipe Pereira, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 347
A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists
Muhammad Osama Yaseen, Arifa Saif, Tahir Mehmood Khan, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 342
Immune-mediated approaches against COVID-19
Helena F. Florindo, Ron Kleiner, Daniella Vaskovich‐Koubi, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 630-645
Open Access | Times Cited: 335
Emerging treatment strategies for COVID-19 infection
Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Eleni Korompoki, et al.
Clinical and Experimental Medicine (2020) Vol. 21, Iss. 2, pp. 167-179
Open Access | Times Cited: 316
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
Mohammed Uddin, Farah Mustafa, Tahir A. Rizvi, et al.
Viruses (2020) Vol. 12, Iss. 5, pp. 526-526
Open Access | Times Cited: 292
Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial
Natàlia Casamitjana, Marc Corbacho-Monné, María Ubals, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 11, pp. e4073-e4081
Open Access | Times Cited: 278
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
Peter Horby, Marion Mafham, Louise Linsell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 239
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
David N. Juurlink
Canadian Medical Association Journal (2020) Vol. 192, Iss. 17, pp. E450-E453
Open Access | Times Cited: 237
Azithromycin in the treatment of COVID-19: a review
Daniel Echeverría-Esnal, Clara Martín‐Ontiyuelo, María Eugenia Navarrete-Rouco, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 2, pp. 147-163
Open Access | Times Cited: 233
Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey
Jean Franco Quispe-Cañari, Evelyn Fidel-Rosales, Diego Manrique, et al.
Saudi Pharmaceutical Journal (2020) Vol. 29, Iss. 1, pp. 1-11
Open Access | Times Cited: 231
Novel coronavirus disease (COVID-19) in children
Hasan Tezer, Tuğba Bedir Demirdağ
TURKISH JOURNAL OF MEDICAL SCIENCES (2020) Vol. 50, Iss. SI-1, pp. 592-603
Open Access | Times Cited: 223
Page 1 - Next Page

Scroll to top